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Despite routine prophylaxis, venous throm-
boembolism remains problematic in the trauma pop-
ulation.1,2 Prophylactic inferior vena cava (IVC) fil-
ters have been shown to be safe and effective in
reducing morbidity and mortality from pulmonary
embolism in high-risk trauma patients.3-6 A contrast
cavagram remains the standard of care before the
insertion of a vena cava filter. Although the nonion-
ic iodinated contrast agents have significantly
reduced the incidence of pain and adverse reactions,
the risk of contrast nephropathy and subsequent
renal failure has not diminished.7 In patients with
elevated serum creatinine levels, the risk of contrast
nephropathy rises exponentially with the level of the
serum creatinine. Duplex ultrasonography scanning
has been reported as an acceptable imaging tech-
nique for IVC filter insertion, but it is associated
with a 10% failure rate for adequate visualization of
the IVC.8 Carbon dioxide (CO2) used as a contrast
agent has no hepatic or renal toxicity and is nonal-
lergenic.9 We report a consecutive series of success-
ful bedside cavagrams with CO2 as a contrast agent.
METHODS
Preinsertion cavagrams and IVC filter inser-
tions were performed at the bedside in the inten-
sive care unit (ICU). Our preferred approach was
to use the right internal jugular vein to decrease
the potential complication of femoral vein throm-
bosis10 and the potential for IVC filter tilt when
using the Greenfield filter (Boston Scientific, Glen
Allen, Va).11
Patients were monitored for physiologic
changes. All patients had cardiac monitoring and
pulse oximetry; seven patients had radial artery
catheters; three patients had noninvasive blood pres-
sure monitored every 2 minutes during the proce-
dure; three of the eight mechanically ventilated
patients had continuous end-tidal CO2 (ETCO2)
monitors (Hewlett-Packard, Andover, Mass); two
patients had indwelling intracranial pressure moni-
tors (with no elevations greater than 18 mm Hg for
at least 24 hours) (Camino Laboratories, Exton, Pa);
and five patients had a pulmonary artery catheter
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with continuous cardiac output monitoring and
continuous mixed venous oxygen saturation mea-
surements (Baxter, Irvine, Calif).
Technique. Patients were prepped and draped
with the use of the sterile technique. The patients
did not require transfer to a specialized stretcher or
unit, because all beds in the ICU are fluoroscopy
ready. A portable digital subtraction/fluoroscopy
unit (OEC Medical Systems, Salt Lake City, Utah)
was used to identify the twelfth thoracic vertebra
and lumbar vertebrae. Guidewire placement, inser-
tion of introducer catheters, and deployment of the
IVC filters were all fluoroscopically guided. The
approach of preference was the right internal jugular
vein unless there was a contraindication (eg, existing
central venous catheter or injury). With the use of
the Seldinger technique, a 9-French introducer
catheter was inserted. A 5-French pigtail angiogra-
phy catheter with radiopaque measuring guides (to
correct for the magnification during fluoroscopy)
(Pig-Cava; Cook Critical Care Inc, Bloomington,
Ind) was advanced into the IVC. Cavagrams were
performed with a hand injection system
(AngioDynamics, Glen Falls, NY) with digital sub-
traction enhancement.12 The pigtail catheter was
positioned at the fourth and fifth lumbar vertebral
interspace. Injections of 60 cc were repeated with a
breath hold if the first cavagram was considered to
be suboptimal. If the renal veins were not identified
with the first cavagram, a separate cavagram was per-
formed with the catheter positioned at the inter-
space between the first and second lumbar vertebrae.
Images were obtained and saved for the permanent
record. Caval size, the location of the iliac bifurca-
tion, and the location of the renal veins were deter-
mined. All IVC filters were then inserted into the
infrarenal position, and a hard copy plain x-ray film
was obtained. The introducer catheter was removed,
and direct pressure to the percutaneous insertion
site was applied for 10 minutes.
RESULTS
Ten patients underwent preinsertion CO2 cava-
grams (Table). Three titanium Greenfield filters
(Boston Scientific), two LGM Vena Tech filters (B.
Braun, Evanston, Ill), and five Bird’s Nest filters
were inserted. Vena Tech filters were inserted into
two patients who were scheduled to have magnetic
resonance imaging (MRI) within 4 weeks of filter
insertion; only the Simon Nitinol (Bard, Salt Lake
City, Utah) and the Vena Tech (Braun) filters are
safe for magnetic resonance imaging immediately
after insertion. Six IVC filters were inserted through
the femoral route, and four were inserted through
the internal jugular vein. Femoral access was used
because two patients had indwelling right internal
jugular catheters, two patients had cervical immobi-
lization, and two patients had both.
Three injections of contrast were needed in seven
patients, two were needed in two patients, and one
was needed in one patient. The iliac bifurcation and
the location of the renal veins were identified in all
patients (Figure). All caval measurements were less
than 28 mm in diameter.
No physiologic changes, including blood pres-
sure, cardiac outputs, mixed venous saturations,
pulse oximetry, or intracranial pressures, occurred
within 10 minutes of the cavagram as a result of the
CO2 injections. In two patients, ETCO2 increased
(8 mm Hg and 10 mm Hg) after a 6-second breath
hold to decrease venous return and enhance the
image quality. In these patients, the ETCO2 increase
was the same, and the increase occurred at the same
time after the breath hold (6 seconds and 10 sec-
Patient characteristics.
Patient Age (y)/sex Injury severity score Creatinine level (mg/dL) Filter type Complications
1 46/M 16 2.8 BN Death*
2 46/F 27 1.1 TG
3 26/M 34 1.6 TG
4 72/M 33 1.3 VT Death*
5 38/M 25 0.8 VT
6 52/M 16 0.7 BN
7 33/M 38 1.0 BN
8 39/F 34 0.7 BN
9 44/F 66 1.5 TG
10 27/M 27 1.0 BN
*Death unrelated to the IVC filter insertion.
BN, Bird’s Nest filter; TG, titanium Greenfield filter; VT, Vena Tech filter.
onds) as in the trial breath holds before the CO2
injections. There were no complaints of pain during
injections in awake patients. Four patients had ele-
vated serum creatinine levels (>1.2 mg/dL) at the
time of their cavagrams. There were no increases in
creatinine levels over the next 96 hours.
DISCUSSION
Carbon dioxide was first used as a contrast agent
in the early 1950s to identify pericardial effusions. In
the 1960s and 1970s it was used in both venous and
arterial angiography.9 The advantages of CO2 are its
lack of side effects, including the absence of renal or
hepatic toxicity, and the ability to be given in repeat-
ed injections without a cumulative effect.9,13 Pain
has been reported with CO2 injections into periph-
eral veins, but it does not occur with IVC injec-
tions.13 The major disadvantage of CO2 is the
requirement for digital subtraction. However, digital
subtraction image quality has rapidly improved over
the past decade, and this technology is now portable
to the bedside. The insertion of IVC filters in the
ICU can be performed with safety and cost-effec-
tiveness while avoiding the risk of transporting criti-
cally ill patients.8,14 Although none of the patients
were hemodynamically unstable, each had devices at
risk for dislodgment during transport from the ICU:
eight patients had endotracheal tubes, which
required mechanical ventilation; five had indwelling
pulmonary artery catheters; two patients had
intracranial pressure monitors; and four had ortho-
pedic or spinal traction devices.
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Carbon dioxide is rapidly dissolved in blood, and
boluses of 100 cc or less are cleared by the lungs in
one pass and cause no changes in arterial pH, pO2,
or pCO2.13 We observed no hemodynamic or respi-
ratory changes during the injections of CO2 or for
10 minutes thereafter. In addition, we demonstrated
that small boluses of 60 cc did not alter ETCO2 or
affect intracranial pressure (patients with normal
intracranial pressures).
Sullivan and colleagues13 described two patients
in whom poor opacification with CO2 underestimat-
ed the cava diameter. We were satisfied with the
opacification for all of our cavagrams. Several
patients required repeated injections for an optimum
image; however, repeated CO2 injections are of no
consequence. The location of the renal veins, the
cava diameter, and the location of the iliac bifurca-
tion were easily identified by bedside CO2 cavogra-
phy in all patients. We are currently initiating a
prospective comparison of CO2 and iodinated con-
trast in determining caval diameter.
In summary, a CO2-contrasted preinsertion ca-
vagram for bedside IVC filter insertions produced
excellent opacification of the IVC, demonstrating
the locations of both the renal veins and the iliac
bifurcation. In patients with elevated serum creati-
nine levels, CO2 contrast is preferable to other con-
trast materials to avoid contrast nephropathy and
renal failure. Because there are few adverse reactions,
CO2 contrast may become the contrast of choice for
the evaluation of the vena cava before the insertion
of IVC filters. Further study is needed to determine
the accuracy of CO2 in measuring caval diameter.
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